Addus HomeCare (ADUS) Stock Price, News & Analysis

Company Overview

Addus HomeCare, Inc. (NASDAQ: ADUS) is a leading provider of in‐home care services, specializing in personal care, companion care, and home health staffing solutions. The company delivers a range of services designed to help seniors and individuals with chronic health conditions maintain their independence and quality of life in the comfort of their own homes. Through its network of state‐licensed agencies and strategic partnerships, Addus HomeCare addresses both medical and non-medical care needs, catering to private pay clients as well as those funded by Medicaid and other government programs.

Founded in the 1970s and headquartered in Frisco, Texas, Addus HomeCare has grown through both organic expansion and targeted acquisitions. Over the years, the company has integrated regional home care agencies to broaden its service offerings and geographic footprint. Significant acquisitions include specialty home health providers and private‐duty care firms, reinforcing Addus’s position in the personal care market and extending capabilities to include home therapy and nursing services when needed.

Today, Addus HomeCare operates across more than 30 states, leveraging a decentralized branch structure that allows each office to tailor care plans to local community needs. The company employs a network of caregivers, nurses and therapists, supported by centralized administrative functions in technology, compliance and human resources. This combination ensures consistent service delivery and regulatory oversight, while allowing flexibility to respond to regional labor markets and client demographics.

The organization is led by President and Chief Executive Officer Ira G. Kose, whose tenure has focused on driving operational efficiency, quality outcomes and strategic growth. Addus’s executive team brings together seasoned professionals in healthcare management, finance and clinical operations, guided by a board of directors committed to advancing best-in-class home care solutions. The company’s ongoing investments in training, technology and safety protocols underscore its commitment to both caregivers and clients in the evolving home care landscape.

Key Stats

• Today's Range: $109.93 to $112.58
• 50-Day Range: $101.03 to $118.00
• 52-Week Range: $88.96 to $136.72
• Volume: 91,160 shs
• Average Volume: 166,252 shs
• Market Capitalization: $2.06 billion
• P/E Ratio: 25.25
• Dividend Yield: N/A
• Price Target: $142.57
• Consensus Rating: Buy

Addus HomeCare Stock Analysis - MarketRank™

Addus HomeCare scored higher than 100% of companies evaluated by MarketBeat, and ranked 17th out of 929 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.6 / 5
• Analyst Rating: Buy

Consensus Rating

Addus HomeCare has received a consensus rating of Buy. The company's average rating score is 3.25, and is based on 6 buy ratings, no hold ratings, and no sell ratings.

Amount of Analyst Coverage

Addus HomeCare has only been the subject of 2 research reports in the past 90 days.

Earnings and Valuation

• Score: 3.1 / 5
• Proj. Earnings Growth: 16.78%

Earnings Growth

Earnings for Addus HomeCare are expected to grow by 16.78% in the coming year, from $4.59 to $5.36 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Addus HomeCare is 25.25, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 25.65.

Price to Earnings Ratio vs. Sector

The P/E ratio of Addus HomeCare is 25.25, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 27.66.

Price to Earnings Growth Ratio

Addus HomeCare has a PEG Ratio of 1.58. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Addus HomeCare has a P/B Ratio of 2.09. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

4.13% of the float of Addus HomeCare has been sold short.

Short Interest Ratio / Days to Cover

Addus HomeCare has a short interest ratio ("days to cover") of 3.7, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Addus HomeCare has recently decreased by 13.35%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Addus HomeCare does not currently pay a dividend.

Dividend Growth

Addus HomeCare does not have a long track record of dividend growth.

Sustainability and ESG

• Score: 5.0 / 5
• Environmental Score: -0.50

Percentage of Shares Shorted

4.13% of the float of Addus HomeCare has been sold short.

Short Interest Ratio / Days to Cover

Addus HomeCare has a short interest ratio ("days to cover") of 3.7, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Addus HomeCare has recently decreased by 13.35%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 2.6 / 5
• News Sentiment: 0.62

News Sentiment

Addus HomeCare has a news sentiment score of 0.62. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.

News Coverage This Week

MarketBeat has tracked 7 news articles for Addus HomeCare this week, compared to 6 articles on an average week.

Search Interest

1 people have searched for ADUS on MarketBeat in the last 30 days.

Company Ownership

• Score: 2.5 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Addus HomeCare insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $253,183.00 in company stock.

Percentage Held by Insiders

Only 4.60% of the stock of Addus HomeCare is held by insiders.

Percentage Held by Institutions

95.35% of the stock of Addus HomeCare is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

ADUS Stock Analysis - Frequently Asked Questions

How have ADUS shares performed this year?

Addus HomeCare's stock was trading at $125.35 on January 1st, 2025. Since then, ADUS stock has decreased by 10.8% and is now trading at $111.86.

How were Addus HomeCare's earnings last quarter?

Addus HomeCare Corporation (NASDAQ:ADUS) posted its quarterly earnings results on Monday, May, 5th. The company reported $1.42 EPS for the quarter, topping analysts' consensus estimates of $1.33 by $0.09. The firm's quarterly revenue was up 20.3% on a year-over-year basis.
Read the conference call transcript.

How do I buy shares of Addus HomeCare?

Shares of ADUS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Addus HomeCare own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Addus HomeCare investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Broadcom (AVGO), Adobe (ADBE), Eli Lilly and Company (LLY) and ServiceNow (NOW).

Company Calendar

• Last Earnings: 5/05/2025
• Today: 7/05/2025
• Next Earnings (Estimated): 8/04/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MED - OUTP/HM CRE
• Sub-Industry: Healthcare
• Current Symbol: NASDAQ:ADUS
• CIK: 1468328
• Web: www.addus.com
• Phone: (469) 535-8200
• Fax: 630-487-2707
• Employees: 49,703
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: $142.57
• High Stock Price Target: $150.00
• Low Stock Price Target: $133.00
• Potential Upside/Downside: +27.5%
• Consensus Rating: Buy
• Rating Score (0-4): 3.25
• Research Coverage: 8 Analysts

Profitability

• EPS (Trailing Twelve Months): $4.43
• Trailing P/E Ratio: 25.25
• Forward P/E Ratio: 24.37
• P/E Growth: 1.58
• Net Income: $73.60 million
• Net Margins: 6.52%
• Pretax Margin: 8.67%
• Return on Equity: 9.23%
• Return on Assets: 6.96%

Debt

• Debt-to-Equity Ratio: 0.20
• Current Ratio: 1.74
• Quick Ratio: 1.74

Sales & Book Value

• Annual Sales: $1.15 billion
• Price / Sales: 1.78
• Cash Flow: $5.39 per share
• Price / Cash Flow: 20.75
• Book Value: $53.52 per share
• Price / Book: 2.09

Miscellaneous

• Outstanding Shares: 18,400,000
• Free Float: 17,553,000
• Market Cap: $2.06 billion
• Optionable: Optionable
• Beta: 0.81